Barry Duplantis
Director of Global Business Development,
Ailux Biologics (XtalPi)
Dr. Barry Duplantis has a strong technical background and over a decade of experience applying drug discovery and development platforms in commercial settings. He was the founder and CEO of a biotech startup and later led client relations at a global contract research organization. Dr. Duplantis earned his Ph.D. from the University of Victoria, where his research focused on intracellular pathogenesis and vaccine development.
Sessions
-
23-Sep-2024Poster Presentation: Cutting through the hype: Real-world applications of AI in antibody discovery and engineering
-
19-Feb-2025Poster Presentation: AI-powered Immune Repertoire Mining and Multi-Objective Antibody Engineering
-
22-Sep-2025Poster Presentation: Lead Identification & Optimization topic: Tackling challenging targets with AI-driven antibody discovery and engineering